A citation-based method for searching scientific literature

Sabine E Hannema, Hermine A van Duyvenvoorde, Thomas Premsler, Ruey-Bing Yang, Thomas D Mueller, Birgit Gassner, Heike Oberwinkler, Ferdinand Roelfsema, Gijs W E Santen, Timothy Prickett, Sarina G Kant, Annemieke J M H Verkerk, André G Uitterlinden, Eric Espiner, Claudia A L Ruivenkamp, Wilma Oostdijk, Alberto M Pereira, Monique Losekoot, Michaela Kuhn, Jan M Wit. J Clin Endocrinol Metab 2013
Times Cited: 50







List of co-cited articles
605 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
Cynthia F Bartels, Hulya Bükülmez, Pius Padayatti, David K Rhee, Conny van Ravenswaaij-Arts, Richard M Pauli, Stefan Mundlos, David Chitayat, Ling-Yu Shih, Lihadh I Al-Gazali,[...]. Am J Hum Genet 2004
226
70

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.
Kohji Miura, Noriyuki Namba, Makoto Fujiwara, Yasuhisa Ohata, Hidekazu Ishida, Taichi Kitaoka, Takuo Kubota, Haruhiko Hirai, Chikahisa Higuchi, Noriyuki Tsumaki,[...]. PLoS One 2012
71
70

Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene.
Kohji Miura, Ok-Hwa Kim, Hey Ran Lee, Noriyuki Namba, Toshimi Michigami, Won Joon Yoo, In Ho Choi, Keiichi Ozono, Tae-Joon Cho. Am J Med Genet A 2014
46
67

Dwarfism and early death in mice lacking C-type natriuretic peptide.
H Chusho, N Tamura, Y Ogawa, A Yasoda, M Suda, T Miyazawa, K Nakamura, K Nakao, T Kurihara, Y Komatsu,[...]. Proc Natl Acad Sci U S A 2001
327
58

Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation.
Renata Bocciardi, Roberto Giorda, Jens Buttgereit, Stefania Gimelli, Maria Teresa Divizia, Silvana Beri, Silvio Garofalo, Sara Tavella, Margherita Lerone, Orsetta Zuffardi,[...]. Hum Mutat 2007
90
50

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature.
Gabriela A Vasques, Naoko Amano, Ana J Docko, Mariana F A Funari, Elisangela P S Quedas, Mirian Y Nishi, Ivo J P Arnhold, Tomonobu Hasegawa, Alexander A L Jorge. J Clin Endocrinol Metab 2013
69
46

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature.
Robert C Olney, Hülya Bükülmez, Cynthia F Bartels, Timothy C R Prickett, Eric A Espiner, Lincoln R Potter, Matthew L Warman. J Clin Endocrinol Metab 2006
115
42

Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
Akihiro Yasoda, Yasato Komatsu, Hideki Chusho, Takashi Miyazawa, Ami Ozasa, Masako Miura, Tatsuya Kurihara, Tomohiro Rogi, Shoji Tanaka, Michio Suda,[...]. Nat Med 2004
261
42

Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.
Naohisa Tamura, Lynda K Doolittle, Robert E Hammer, John M Shelton, James A Richardson, David L Garbers. Proc Natl Acad Sci U S A 2004
200
36

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature.
Sophie R Wang, Christina M Jacobsen, Heather Carmichael, Aaron B Edmund, Jerid W Robinson, Robert C Olney, Timothy C Miller, Jennifer E Moon, Veronica Mericq, Lincoln R Potter,[...]. Hum Mutat 2015
55
36

Identification and functional characterization of two novel NPR2 mutations in Japanese patients with short stature.
Naoko Amano, Tokuo Mukai, Yoshiya Ito, Satoshi Narumi, Toshiaki Tanaka, Susumu Yokoya, Tsutomu Ogata, Tomonobu Hasegawa. J Clin Endocrinol Metab 2014
46
34

Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.
Rumi Hachiya, Yuko Ohashi, Yasutomi Kamei, Takayoshi Suganami, Hiroshi Mochizuki, Norimasa Mitsui, Masaaki Saitoh, Masako Sakuragi, Gen Nishimura, Hirofumi Ohashi,[...]. J Clin Endocrinol Metab 2007
48
31

A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype.
Anne Moncla, Chantal Missirian, Pierre Cacciagli, Eve Balzamo, Laurence Legeai-Mallet, Jean-Luc Jouve, Brigitte Chabrol, Martine Le Merrer, Ghislaine Plessis, Laurent Villard,[...]. Hum Mutat 2007
61
30



Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Florence Lorget, Nabil Kaci, Jeff Peng, Catherine Benoist-Lasselin, Emilie Mugniery, Todd Oppeneer, Dan J Wendt, Sean M Bell, Sherry Bullens, Stuart Bunting,[...]. Am J Hum Genet 2012
101
24

Novel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteaux.
Saadullah Khan, Raja Hussain Ali, Sanaullah Abbasi, Muhammad Nawaz, Noor Muhammad, Wasim Ahmad. BMC Med Genet 2012
25
44

Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
Akihiro Yasoda, Hidetomo Kitamura, Toshihito Fujii, Eri Kondo, Naoaki Murao, Masako Miura, Naotetsu Kanamoto, Yasato Komatsu, Hiroshi Arai, Kazuwa Nakao. Endocrinology 2009
78
22


Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway.
A Yasoda, Y Ogawa, M Suda, N Tamura, K Mori, Y Sakuma, H Chusho, K Shiota, K Tanaka, K Nakao. J Biol Chem 1998
155
20

A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B.
Jerid W Robinson, Deborah M Dickey, Kohji Miura, Toshimi Michigami, Keiichi Ozono, Lincoln R Potter. Bone 2013
16
62

The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth.
Kazumasa Nakao, Kenji Osawa, Akihiro Yasoda, Shigeki Yamanaka, Toshihito Fujii, Eri Kondo, Noriaki Koyama, Naotetsu Kanamoto, Masako Miura, Koichiro Kuwahara,[...]. Sci Rep 2015
42
23

Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.
Daniel J Wendt, Melita Dvorak-Ewell, Sherry Bullens, Florence Lorget, Sean M Bell, Jeff Peng, Sianna Castillo, Mika Aoyagi-Scharber, Charles A O'Neill, Pavel Krejci,[...]. J Pharmacol Exp Ther 2015
55
20

C-natriuretic peptide: an important regulator of cartilage.
Katerina Pejchalova, Pavel Krejci, William R Wilcox. Mol Genet Metab 2007
45
20

Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.
Pavel Krejci, Bernard Masri, Vincent Fontaine, Pertchoui B Mekikian, Maryann Weis, Herve Prats, William R Wilcox. J Cell Sci 2005
104
18

Amino-terminal propeptide of C-type natriuretic peptide (NTproCNP) predicts height velocity in healthy children.
Robert C Olney, Joseph W Permuy, Timothy C R Prickett, Joan C Han, Eric A Espiner. Clin Endocrinol (Oxf) 2012
32
25

C-type natriuretic peptide in growth: a new paradigm.
Robert C Olney. Growth Horm IGF Res 2006
52
16

Hundreds of variants clustered in genomic loci and biological pathways affect human height.
Hana Lango Allen, Karol Estrada, Guillaume Lettre, Sonja I Berndt, Michael N Weedon, Fernando Rivadeneira, Cristen J Willer, Anne U Jackson, Sailaja Vedantam, Soumya Raychaudhuri,[...]. Nature 2010
16

Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
Ami Ozasa, Yasato Komatsu, Akihiro Yasoda, Masako Miura, Yoko Sakuma, Yuko Nakatsuru, Hiroshi Arai, Nobuyuki Itoh, Kazuwa Nakao. Bone 2005
43
18

Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.
R Shiang, L M Thompson, Y Z Zhu, D M Church, T J Fielder, M Bocian, S T Winokur, J J Wasmuth. Cell 1994
914
16

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
N Matsukawa, W J Grzesik, N Takahashi, K N Pandey, S Pang, M Yamauchi, O Smithies. Proc Natl Acad Sci U S A 1999
305
16

C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
Robert C Olney, Timothy C R Prickett, Eric A Espiner, William G Mackenzie, Angela L Duker, Colleen Ditro, Bernhard Zabel, Tomonobu Hasegawa, Hiroshi Kitoh, Arthur S Aylsworth,[...]. J Clin Endocrinol Metab 2015
18
44

A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.
Reha M Toydemir, Anna E Brassington, Pinar Bayrak-Toydemir, Patrycja A Krakowiak, Lynn B Jorde, Frank G Whitby, Nicola Longo, David H Viskochil, John C Carey, Michael J Bamshad. Am J Hum Genet 2006
85
16

Defining the role of common variation in the genomic and biological architecture of adult human height.
Andrew R Wood, Tonu Esko, Jian Yang, Sailaja Vedantam, Tune H Pers, Stefan Gustafsson, Audrey Y Chu, Karol Estrada, Jian'an Luan, Zoltán Kutalik,[...]. Nat Genet 2014
975
16

C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways.
Hanga Agoston, Sameena Khan, Claudine G James, J Ryan Gillespie, Rosa Serra, Lee-Anne Stanton, Frank Beier. BMC Dev Biol 2007
66
14

A novel loss-of-function mutation in Npr2 clarifies primary role in female reproduction and reveals a potential therapy for acromesomelic dysplasia, Maroteaux type.
Krista A Geister, Michelle L Brinkmeier, Minnie Hsieh, Susan M Faust, I Jill Karolyi, Joseph E Perosky, Kenneth M Kozloff, Marco Conti, Sally A Camper. Hum Mol Genet 2013
40
17

Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification.
Cristina C Teixeira, Hanga Agoston, Frank Beier. Dev Biol 2008
50
14

A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly.
Periklis Makrythanasis, Samia Temtamy, Mona S Aglan, Ghada A Otaify, Hanan Hamamy, Stylianos E Antonarakis. Hum Mutat 2014
36
19

Role of the natriuretic peptide system in normal growth and growth disorders.
Gabriela A Vasques, Ivo J P Arnhold, Alexander A L Jorge. Horm Res Paediatr 2014
32
21

Heterozygous NPR2 Mutations Cause Disproportionate Short Stature, Similar to Léri-Weill Dyschondrosteosis.
Alfonso Hisado-Oliva, Ana I Garre-Vázquez, Fabiola Santaolalla-Caballero, Alberta Belinchón, Ana C Barreda-Bonis, Gabriela A Vasques, Joaquin Ramirez, Cristina Luzuriaga, Gianni Carlone, Isabel González-Casado,[...]. J Clin Endocrinol Metab 2015
42
16

Acromesomelic dysplasia, type maroteaux caused by novel loss-of-function mutations of the NPR2 gene: Three case reports.
Wei Wang, Mi Hyun Song, Kohji Miura, Makoto Fujiwara, Nobutoshi Nawa, Yasuhisa Ohata, Taichi Kitaoka, Takuo Kubota, Noriyuki Namba, Dong Kyu Jin,[...]. Am J Med Genet A 2016
17
41



Bi-allelic Loss-of-Function Mutations in the NPR-C Receptor Result in Enhanced Growth and Connective Tissue Abnormalities.
Eveline Boudin, Tjeerd R de Jong, Tim C R Prickett, Bruno Lapauw, Kaatje Toye, Viviane Van Hoof, Ilse Luyckx, Aline Verstraeten, Hugo S A Heymans, Eelco Dulfer,[...]. Am J Hum Genet 2018
9
77


Synthesizing genome-wide association studies and expression microarray reveals novel genes that act in the human growth plate to modulate height.
Julian C Lui, Ola Nilsson, Yingleong Chan, Cameron D Palmer, Anenisia C Andrade, Joel N Hirschhorn, Jeffrey Baron. Hum Mol Genet 2012
46
13

Achondroplasia.
William A Horton, Judith G Hall, Jacqueline T Hecht. Lancet 2007
266
12

Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification.
Takashi Miyazawa, Yoshihiro Ogawa, Hideki Chusho, Akihiro Yasoda, Naohisa Tamura, Yasato Komatsu, Alexander Pfeifer, Franz Hofmann, Kazuwa Nakao. Endocrinology 2002
84
12

Granulosa cell ligand NPPC and its receptor NPR2 maintain meiotic arrest in mouse oocytes.
Meijia Zhang, You-Qiang Su, Koji Sugiura, Guoliang Xia, John J Eppig. Science 2010
301
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.